Research and Markets has announced the addition of the "Trans-Pacific Partnership Summary Report on the Pharmaceutical Industry" report to their offering.

An analysis on the Trans-Pacific Partnership (TPP) and its effects on the US Pharmaceutical industry with TPP trading partners. The TPP is a global free trade agreement that includes 12 nations around the pacific rim, but excludes key countries like China and India. This highly debated trade agreement goes to a congressional vote at the end of 2016, as such every company and industry will need to understand the impact it will have on their organization. Included in the report are details of the opportunities and risks, and trade data.

Our report provides a current status of the TPP agreement, including what each of the two key countries, Japan and the USA, need to do to ratify the agreement, and the impact if they do not. The report then details the current trading statistics between the USA and the TPP nations, and provides a review of how the TPP will affect the overall industry and key areas impacted.

The report then concludes with insights into the major risks and opportunities the TPP will provide to the Pharmaceutical Industry.

Key Topics Covered:

Section 1 - Overview of the TPP agreement

Section 2 - Current Status of the TPP

Section 3 - Overview of the US Pharmaceutical Trade with TPP countries

Section 4 - Key Chapters in the TPP that will impact the Pharmaceutical industry

Section 5 - Threats to the Pharmaceutical industry

Section 6 - Opportunities to the Pharmaceutical industry

Section 7 - Conclusion

For more information visit http://www.researchandmarkets.com/research/v8k5z9/transpacific

Research and MarketsLaura Wood, Senior Managerpress@researchandmarkets.comFor E.S.T Office Hours Call 1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT Office Hours Call +353-1-416-8900U.S. Fax: 646-607-1907Fax (outside U.S.): +353-1-481-1716Sector: Pharmaceuticals, International Trade